Company profile
Kymera Therapeutics, Inc. insider acquisitions
Company CIK 0001815442 · Reported insider acquisitions and filing context.
These are company listings. A transaction is linked to a particular security only when the filing provides enough information.
Company activity summary
By transaction date, as of October 23, 2026.
No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.
Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.
Transaction timeline
Who reported an acquisition, and when the transaction occurred.
17 dated transactions · 8 of 10 reporting owners shown. Select one owner to focus the chart.
View timeline as a table
| Transaction date | Company / security | Reporting owners | Acquisition type |
|---|---|---|---|
| Oct 1, 2026 | Kymera Therapeutics, Inc.Common Stock | Mainolfi Nello | Exercise / conversion |
| Dec 31, 2025 | Kymera Therapeutics, Inc.Common Stock | Mainolfi Nello | Exercise / conversion |
| Dec 17, 2025 | Kymera Therapeutics, Inc.Common Stock | Mainolfi Nello | Exercise / conversion |
| Dec 17, 2025 | Kymera Therapeutics, Inc.Common Stock | Esposito Pamela | Exercise / conversion |
| Dec 17, 2025 | Kymera Therapeutics, Inc.Common Stock | Esposito Pamela | Exercise / conversion |
| Dec 17, 2025 | Kymera Therapeutics, Inc.Common Stock | Esposito Pamela | Exercise / conversion |
| Dec 11, 2025 | Kymera Therapeutics, Inc.Common Stock | BAKER JULIAN · BAKER FELIX · BAKER BROS. ADVISORS LP · Baker Brothers Life Sciences LP · 667, L.P. · Baker Bros. Advisors (GP) LLC | Purchase |
| Dec 11, 2025 | Kymera Therapeutics, Inc.Common Stock | BAKER JULIAN · BAKER FELIX · BAKER BROS. ADVISORS LP · Baker Brothers Life Sciences LP · 667, L.P. · Baker Bros. Advisors (GP) LLC | Purchase |
| Dec 8, 2025 | Kymera Therapeutics, Inc.Common Stock | Albers Jeffrey W. | Exercise / conversion |
| Dec 8, 2025 | Kymera Therapeutics, Inc.Common Stock | Mainolfi Nello | Exercise / conversion |
| Dec 8, 2025 | Kymera Therapeutics, Inc.Common Stock | Gollob Jared | Exercise / conversion |
| Oct 29, 2025 | Kymera Therapeutics, Inc.Common Stock | Mainolfi Nello | Exercise / conversion |
| Oct 15, 2025 | Kymera Therapeutics, Inc.Common Stock | Gollob Jared | Exercise / conversion |
| Oct 15, 2025 | Kymera Therapeutics, Inc.Common Stock | Gollob Jared | Exercise / conversion |
| Oct 13, 2025 | Kymera Therapeutics, Inc.Common Stock | Gollob Jared | Exercise / conversion |
| Oct 13, 2025 | Kymera Therapeutics, Inc.Common Stock | Gollob Jared | Exercise / conversion |
| Oct 13, 2025 | Kymera Therapeutics, Inc.Common Stock | Albers Jeffrey W. | Exercise / conversion |
Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.
Share price & reported acquisitions
Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.
Price history is not available
Market-price history is not connected yet.
KYMR · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.
Reported acquisitions
Filing-date filters apply to the list and timeline. The summary above uses transaction dates.
| Filed / transacted | Reporting owners | Type / security | Quantity | Price / reference value | Details |
|---|---|---|---|---|---|
| Trade: | Mainolfi NelloChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 30,000 | 2.08Value: 62,400Currency not specified | View ↗ |
| Trade: | Mainolfi NelloChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 30,000 | 2.08Value: 62,400Currency not specified | View ↗ |
| Trade: | Mainolfi NelloChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 2,595 | 38.53Value: 99,985.35Currency not specified | View ↗ |
| Trade: | Esposito PamelaDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 3,000 | 31.2Value: 93,600Currency not specified | View ↗ |
| Trade: | Esposito PamelaDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 12,000 | 27.67Value: 332,040Currency not specified | View ↗ |
| Trade: | Esposito PamelaDirector | Exercise / conversionCommon StockNon-derivative security · Code M | 12,563 | 49.1Value: 616,843.3Currency not specified | View ↗ |
| Trade: | BAKER JULIANDirector · 10% owner BAKER FELIXDirector · 10% owner BAKER BROS. ADVISORS LPDirector · 10% owner Baker Brothers Life Sciences LPDirector · 10% owner 667, L.P.Director · 10% owner Baker Bros. Advisors (GP) LLCDirector · 10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 1,838,621 | 86Value: 158,121,406Currency not specified | View ↗ |
| Trade: | BAKER JULIANDirector · 10% owner BAKER FELIXDirector · 10% owner BAKER BROS. ADVISORS LPDirector · 10% owner Baker Brothers Life Sciences LPDirector · 10% owner 667, L.P.Director · 10% owner Baker Bros. Advisors (GP) LLCDirector · 10% owner Joint filing · amounts unallocated | PurchaseCommon StockNon-derivative security · Code P | 167,192 | 86Value: 14,378,512Currency not specified | View ↗ |
| Trade: | Albers Jeffrey W.Director | Exercise / conversionCommon StockNon-derivative security · Code M | 5,000 | 14.18Value: 70,900Currency not specified | View ↗ |
| Trade: | Mainolfi NelloChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 100,000 | 2.08Value: 208,000Currency not specified | View ↗ |
| Trade: | Gollob JaredChief Medical Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 49,307 | 5.33Value: 262,806.31Currency not specified | View ↗ |
| Trade: | Mainolfi NelloChief Executive Officer · Director | Exercise / conversionCommon StockNon-derivative security · Code M | 30,000 | 2.08Value: 62,400Currency not specified | View ↗ |
| Trade: | Gollob JaredChief Medical Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 22,210 | 2.08Value: 46,196.8Currency not specified | View ↗ |
| Trade: | Gollob JaredChief Medical Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 28,999 | 1.31Value: 37,988.69Currency not specified | View ↗ |
| Trade: | Gollob JaredChief Medical Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 673 | 2.08Value: 1,399.84Currency not specified | View ↗ |
| Trade: | Gollob JaredChief Medical Officer | Exercise / conversionCommon StockNon-derivative security · Code M | 800 | 1.31Value: 1,048Currency not specified | View ↗ |
| Trade: | Albers Jeffrey W.Director | Exercise / conversionCommon StockNon-derivative security · Code M | 5,000 | 10.34Value: 51,700Currency not specified | View ↗ |
17 transactions on this page. Filing date, newest first.
Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →